Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,600 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
CD4+FOXP3Exon2+ regulatory T cell frequency predicts breast cancer prognosis and survival.
Fusco C, Di Rella F, Liotti A, Colamatteo A, Ferrara AL, Gigantino V, Collina F, Esposito E, Donzelli I, Porcellini A, Feola A, Micillo T, Perna F, Garziano F, Maniscalco GT, Varricchi G, Mottola M, Zuccarelli B, De Simone B, di Bonito M, Matarese G, Accurso A, Pontillo M, Russo D, Insabato L, Spaziano A, Cantone I, Pezone A, De Rosa V. Fusco C, et al. Among authors: russo d. Sci Adv. 2025 Jan 17;11(3):eadr7934. doi: 10.1126/sciadv.adr7934. Epub 2025 Jan 15. Sci Adv. 2025. PMID: 39813341
Early assessment of IL8 and PD1+ Treg predicts response and guides treatment monitoring in cemiplimab-treated cutaneous squamous cell carcinoma.
Esposito D, Napolitano F, Maresca DC, Scala M, Amato A, Belli S, Ascione CM, Vallefuoco A, Attanasio G, Somma F, Ianaro A, Russo D, Varricchio S, Mascolo M, Costa C, Villani A, Scalvenzi M, Orlandino G, Troiani T, Servetto A, Bianco R, Ercolano G, Formisano L. Esposito D, et al. Among authors: russo d. J Immunother Cancer. 2025 Jan 11;13(1):e010421. doi: 10.1136/jitc-2024-010421. J Immunother Cancer. 2025. PMID: 39800379 Free article.
Stereotactic body radiotherapy and poly (ADP-ribose) polymerase inhibitors in ovarian cancer: a knowledge and attitudes survey in collaboration with the Italian Association of Radiation Oncology (AIRO) and Multicenter Italian Trials in Ovarian Cancer (MITO) groups.
Macchia G, Pezzulla D, Russo D, Campitelli M, Lucci S, Fanelli M, Deodato F, Fagotti A, Gambacorta MA, Savarese A, Pignata S, Aristei C, Ferrandina G. Macchia G, et al. Among authors: russo d. Anticancer Drugs. 2025 Jan 8. doi: 10.1097/CAD.0000000000001684. Online ahead of print. Anticancer Drugs. 2025. PMID: 39784120
Invasive infections by group A Streptococcus infections in Brazil: a pediatric case series.
Russo DO, Moreira MM, Bentes AA, Marques BA, Carellos EVM, Nogueira FD, Romanelli RMC, Jimenez ALL, Souza CCV, Moreira LC, Parreira MP, Avendanha RA, Santos RCCD, Arantes Junior MAF, Diniz LMO. Russo DO, et al. Rev Paul Pediatr. 2024 Dec 20;43:e2024100. doi: 10.1590/1984-0462/2025/43/2024100. eCollection 2024. Rev Paul Pediatr. 2024. PMID: 39775609 Free PMC article.
Unraveling the complexity of HRD assessment in ovarian cancer by combining genomic and functional approaches: translational analyses of MITO16-MaNGO-OV-2 trial.
Pellegrino B, Capoluongo ED, Bagnoli M, Arenare L, Califano D, Scambia G, Cecere SC, Silini EM, Scaglione GL, Spina A, Tognon G, Campanini N, Pisano C, Russo D, Pettinato A, Scollo P, Iemmolo R, De Cecco L, Musolino A, Marchini S, Beltrame L, Paracchini L, Perrone F, Mezzanzanica D, Pignata S. Pellegrino B, et al. Among authors: russo d. ESMO Open. 2025 Jan 3;10(1):104091. doi: 10.1016/j.esmoop.2024.104091. Online ahead of print. ESMO Open. 2025. PMID: 39754985 Free article.
1,600 results